Clinical trials
Phase 2 Rhabdomyosarcoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2013 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Grupo Espanol de Investigacion en Sarcomas | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Herbert Irving Comprehensive Cancer Center | 1 |
| Samsung Medical Center | 1 |
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhabdomyosarcoma | 6 |
| Sarcoma | 4 |
| Osteosarcoma | 3 |
| Sarcoma, Ewing | 3 |
| Fibrosarcoma | 2 |
| Hemangiosarcoma | 2 |
| Histiocytoma, Malignant Fibrous | 2 |
| Leiomyosarcoma | 2 |
| Liposarcoma | 2 |
| Neuroblastoma | 2 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.